BPR-5K230

N/A

Report date: 2024/05/13 10:59:29
NME

Base Information

Drug NameBPR-5K230
Drug Alias NameBPR-5K230
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase inhibitorsTyrosine-protein kinase Mer inhibitorsImmunomodulators
TargetsAXL receptor tyrosine kinaseTyrosine-protein kinase Mer
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcademia SinicaNational Health Research Institutes
China Registration ClassN/A

Develop Information

Active CompaniesAcademia SinicaNational Health Research Institutes
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A